LEVOTHYROXINE SODIUM Recall D-0336-2023
Description: TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0112-5
LEVOTHYROXINE SODIUM Recall D-0336-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0336-2023 |
Event ID | 91556 |
Brand | TIROSINT |
Generic Name | LEVOTHYROXINE SODIUM |
Manufacturer | LEVOTHYROXINE SODIUM |
Original Package? | 1 |
Active Substance | LEVOTHYROXINE SODIUM |
Drug Route | ORAL |
Distribution | Nationwide in the USA. |
Recall Reason | Subpotent Drug |
Drug Classification | Class I |
Drug Code Info | 20230301 |
Product NDC | 71858-0105 71858-0110 71858-0112 |
Recall Initiation Date | 20230130 |
Report Date | 20230301 |
Classification Date | 20230221 |
Address | 8 Campus Dr Ste 201 Parsippany, NJ 07054-4409 United States |
Recalling Firm | IBSA PHARMA INC |
Initial Notification | Letter |
Unique Ingredient Identifier | 9J765S329G |
Drug Application Number | NDA206977 |
Structured Product Labeling (SPL ID) | f1d5f04c-48ff-6a9f-e053-2a95a90a5f81 |
Structured Product Labeling (SPL Set ID) | 5d378add-f13d-40f2-99dc-0f2340ab44b7 |
Similar To |